Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT
Year: 2020
Type: article
Study design: Observational Study
Source: Bone Marrow Transplantation
Authors: Arnon Nagler, Frédéric Baron, Myriam Labopin, Emmanuel Polge, Jordi Esteve, Ali Bazarbachi, Eolia Brissot, Gesine Bug, Fabio Ciceri, Sebastian Giebel, Maria H. Gilleece, Norbert-Claude Gorin, Francesco Lanza, Zinaida Peric, Annalisa Ruggeri, Jaime Sanz, Bipin N. Savani, Christoph Schmid, Roni Shouval, Alexandros Spyridonidis, Jurjen Versluis, Mohamad Mohty
Institutions: Tel Aviv University, Sheba Medical Center, Hôpital Saint-Antoine, European Society for Blood and Marrow Transplantation, University of Liège, Inserm, Sorbonne Université, Hospital Clínic de Barcelona, American University of Beirut Medical Center, Goethe University Frankfurt, University Hospital Frankfurt, IRCCS Ospedale San Raffaele, The Maria Sklodowska-Curie National Research Institute of Oncology, University Hospital Centre Zagreb, Hospital Universitari i Politècnic La Fe, Vanderbilt University Medical Center, University Hospital Augsburg, Memorial Sloan Kettering Cancer Center, University of Patras, Erasmus MC, Erasmus MC Cancer Institute
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3045586285